FFA
TLSI icon

Farther Finance Advisors’s TriSalus Life Sciences TLSI Stock Holding History

Farther Finance Advisors’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$357 Buy
78
+77
+7,700% +$306 ﹤0.01% 5605
2026
Q1 		$4 Buy
+1
New +$5 ﹤0.01% 5717

Other funds holding TLSI

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
HRC
Hoertkorn Richard Charles $149M AUM 77.22% 1-Year Est. Return
RDFA
Ritter Daniher Financial Advisory Cincinnati, Ohio $657M AUM 20.27% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Farther Finance Advisors's TLSI Position: Q2 2026 in Review

Farther Finance Advisors increased its TriSalus Life Sciences (TLSI) stake by 7,700% in Q2 2026, buying an estimated $306 and bringing the position to 78 shares worth $357. The position accounts for ﹤0.01% of the portfolio, ranked #5605.

Farther Finance Advisors first reported a position in TLSI in Q1 2026 and has held it in 2 quarters since. 12 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • Farther Finance Advisors held 78 shares of TriSalus Life Sciences worth $357 as of Q2 2026.
  • Farther Finance Advisors bought 77 TriSalus Life Sciences shares in Q2 2026, an estimated $306.
  • TriSalus Life Sciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5605 holding.
  • Farther Finance Advisors first reported a position in TriSalus Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 12 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.